Charles River Laboratories (NYSE:CRL) reported Q1 2018 earnings this Morning, coming in at $1.38 per share, beating Wall Street’s estimates of $1.26 per Share. Revenue for the quarter came in at $493.97 million beating analyst estimates of $480.03 million Recent Insider Trading for Charles River Laboratories (NYSE:CRL)
- On 5/1/2018 David Ross Smith, Insider, sold 945 with an average share price of $104.23 per share and the total transaction amounting to $98,497.35.
- On 3/9/2018 George M Milne Jr, Director, sold 7,740 with an average share price of $115.00 per share and the total transaction amounting to $890,100.00.
- On 3/6/2018 Birgit Girshick, Insider, sold 9,893 with an average share price of $109.10 per share and the total transaction amounting to $1,079,326.30.
- On 3/6/2018 James C Foster, CEO, sold 24,008 with an average share price of $110.00 per share and the total transaction amounting to $2,640,880.00.
- On 2/28/2018 David Ross Smith, CFO, sold 100 with an average share price of $108.43 per share and the total transaction amounting to $10,843.00.
- On 2/28/2018 James C Foster, CEO, sold 3,372 with an average share price of $107.39 per share and the total transaction amounting to $362,119.08.
Dividend History for Charles River Laboratories (NYSE:CRL)
Recent Trading for Charles River Laboratories (NYSE:CRL) Shares of Charles River Laboratories closed the previous trading session at 107.00 up +1.50 1.42% with shares trading hands.